In conclusion, YAP inhibitors combined with phototherapy can alleviate the factors affecting the immune response, such as immune deficiency, thereby enhancing the efficiency and intensity of phototherapy-induced ICD. The gene discussed is YAP1; the disease is Immunodeficiency.